The fall of 23andMe raises privacy concerns as Regeneron buys its genetic database for $256M after bankruptcy.

If DNA bridges persist between chromosomes during cell division, chromosomes are abnormally segregated, leading to genetic instability and cancer. Researchers at UNIST and IBS have experimentally revealed for the first time how a critical protein acts as a last resort to eliminate these dangerous DNA bridges,

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.

Rivian and VW struck a $5 billion deal last year to form a joint venture to develop next-generation EV technology.

On Thursday, jurors heard testimony from a doctor with the state’s Chief Medical Examiner’s Office about the injuries to O’Keefe and the conclusions of the autopsy she performed. Testimony resumes when the court is back in session at 9 a.m. This post will be updated as testimony gets underway.

Thao Xiong, 59, already faced a January charge of raping a 71-year-old in St. Paul. He’s been on probation since 2020 for a 2019 sexual assault.

Regeneron Pharmaceuticals plans to purchase 23andMe just two months after the genetics company filed for bankruptcy.